Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Assessment of Fluticasone Propionate/ Salmeterol Xinafoate HFA MDI in 6-month to 4-year-old Japanese Patients With Bronchial Asthma

NCT02113436 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT02113436
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02113436 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Assessment of Fluticasone Propionate/ Salmeterol Xinafoate HFA MDI in 6-month to 4-year-old Japanese Patients With Bronchial Asthma
Lead sponsor
GlaxoSmithKline
Phase
Phase 4
Overall status
Completed
Start date
May 1, 2014
Completion date
October 1, 2016
Enrollment
300 (actual)
Sites
69

Conditions

As the registry lists them; a condition with its own page is linked.

asthma